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ABSTRACT 
The research worked based using solid dispersion method though poorly soluble drugs lovastatin formulating it as solid disper sions 
subsequent preparation of fast dissolving tablets with the prepared solid dispersions using different concentrations of super disintegrates and 
comparing them with that of the marketed product. Lovastatin is a HMG CoA reductase inhibitor used in the treatment of hyperlipidemias and 
prevention of ischemic heart disease. It is practically insoluble in water, sparingly soluble in alcohol and soluble in acetone. In the present 
investigation lovastatin and solid dispersion were prepared by physical mixing, fusion, solvent evaporation and lyophilizafio n methods using 
polyethylene glycol-6000 as an inert amphiphilc carrier. The prepared solid dispersions were evaluated for pre compressional parameters such 
as angle of repose, Carr’s index, particle size and drug content.  
Keywords: solid dispersion, poorly soluble drugs, super disintegrates. 
 
Article Info: Received 13 Feb 2019;     Review Completed 22 March 2019;     Accepted 15 April 2019;     Available online 25 April 2019 
Cite this article as: 
Chouhan M, Gupta D, Choukse R, Maheshwari RK, Formulation and evaluation fast dissolving tablets of lovastatin using 
solid dispersion method, Journal of Drug Delivery and Therapeutics. 2019; 9(2-A):29-31      
*Address for Correspondence:  
Manohar Chouhan, Dr AJP Abdul Kalam University, Indore (M.P) India 
 
 
INTRODUCTION 
Solid dispersion method of dispersion of active ingredient in 
an inert carrier or matrix at solid state has prepared by the 
melting (fusion), solvent or the melting solvent method. 
Solid products consists of at least two different components, 
generally a hydrophilic matrix and a hydrophobic drugs. The 
matrix may be crystalline or amorphous. The drag can be 
dispersed molecularly, in amorphous particles (clusters) or 
in crystalline particles1, 2. 
Solid dispersions are of six types based on the molecular 
arrangement. 
1. Simple eutectic mixtures 
2. Amorphous precipitation in crystalline matrix 
3. Solid solutions 
 Continuous solid solutions 
 Discontinuous solid solutions 
 Substitution solid solutions 
 Interstitial solid solutions 
4. Glass suspension 
5. Glass solution 
6. Complex formation between the drug and carrier 
MATERIAL AND METHOD 
Lovastatin given to gift sample of Zeiss pharmaceutical 
Badhi(H.P), pregelatinised starch, sodium starch glyeolate, 
crose armellose sodium , polyethylene glycol 6000  and  
crospovidone etc. 
Saturated Solubility Studies of Lovastatin 
Saturated solubility of lovastatin was performed in different 
dissolution media. 500mg of lovastatin was weighed and 
transferred into different conical flasks. 50ml of different 
dissolution media were transferred into individual conical 
flasks and were closed appropriately. All the conical flasks 
were placed in the REMI incubator shaker. The shaker was 
allowed to operate at 50 rpm at 37° C ± 1° C for 24 hrs. Then 
the conical flasks were removed from the incubator shaker 
and the samples were filtered by using what man filter 
paper. The clear solution obtained by filtration was suitably 
diluted with appropriate dissolution media and the 
absorbance values were noted at 238 nm by using 
corresponding dissolution media as blank solutions.  
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The methods employed for the preparation of solid 
dispersions are: 
1. Physical mixing. 
2. Fusion method 
3. Solvent evaporation 
4. Lyophilization  
Physical Mixing:  
Specified quantity of drug and polyethylene glycol 6000 
were weighed separately and passed separately through 
sieve no 80. The materials passed through sieve no.80 were 
collected and transferred into a clean and dry glass mortar. 
Drug and PEG- 6000 were triturated together and again 
screened through sieve no 100. The mixture passed through 
sieve no 100 was collected and packed in a wide mouthed 
amber coloured glass container and was hermetically sealed. 
Then the mixture was stored at ambient conditions. 
Fusion Method:  
Specified quantity of PEG-6000 was taken in a china dish and 
it was heated at on a mantle until molten mass was formed. 
To the molten mass specified quantity of drug was added 
and triturated vigorously at room temperature. The mixture 
obtained was triturated thoroughly in a glass mortar and 
screened through sieve no. 100. Then the mixture was 
collected, packed in a wide mouthed amber coloured glass 
container and was hermetically sealed. Then the mixture 
was stored at ambient conditions. 
Solvent Evaporation:  
Specified quantity of drug was taken in a china dish and it 
was dissolved in few ml of methanol. To the methanolic 
solution, specified amount of PEG-6000 was added and the 
solvent was evaporated under vacuum using Rota flash 
evaporator. The mixture obtained was triturated thoroughly 
in a glass mortar and screened through sieve no. 100. Then 
the mixture was collected, packed in a wide mouthed amber 
coloured glass container and was hermetically sealed. Then 
the mixture was stored at ambient conditions. 
Lyophilization: 
Specified quantity of drug and PEG-6000 were weighed 
added with minimum amount of water. This dispersion was 
rapidly solidified by freezing in the IL Shin freeze drier (Shin 
Lab Co., Ltd). The solvent in the dispersion was sublimed 
under a pressure of 10 M tore and condensed onto a -40°C 
condenser. After the solvent was completely removed, the 
powder residue appeared as a porous, light and puffy mass. 
The lyophilized preparations were stored in a desiccator at 
room temperature. The compositions of various solid 
dispersions were given. 
Drug Release Studies Solid Dispersions of Lovastatin 
Solid Dispersions: 
Dissolution studies on solid dispersions were performed in a 
calibrated eight stage dissolution rate test apparatus 
equipped with paddles employing 900 ml of 7.0 pH 
phosphate buffer as a medium. The paddles were operated 
at 50 rpm and the temperature was maintained at 37±0.5°C 
throughout the experiment. Samples were withdrawn at 5, 
10, 15, 20, 30, 45, 60 minutes and replaced with equal 
volume to maintain the constant volume of dissolution 
medium throughout the experiment. Drug content of the 
samples was determined by double beam UV 
spectrophotometer at 238 nm after suitable dilutions of the 
samples. 
Absorbance data for calibration curve of Lovastatin at 
238 nm 
Concentration  Absoption 
2 0.476 
4 0.678 
6 0.690 
8 0.710 
10 0.890 
                 
  Calibration Curve for the Estimation of Lovastatin 
 
 
Differential Scanning Calorimetry (DSC): 
A differential scanning calorimeter (DSC 60, Shimadzu) was 
used to obtain the DSC curves of solid dispersions prepared 
by fusion, solvent evaporation and lyophilization methods 
representing the rate of heat uptake. About 10 mg of sample 
was weighed in a standard open al pans, and scanned from 
20-300°C, at a heating rate of 10°C/minute while being 
purged with dry nitrogen. 
RESULT 
The lovastatin solid dispersions which shows better 
dissolution rate were then formulated as fast dissolving 
tablets by using newer super disintegrates such as 
pregelatinised starch, sodium starch glyeolate, crose 
armellose sodium, crospovidone. All the tablet formulations 
were evaluated for physical parameters such as weight 
uniformity, hardness, friability, wetting time, dispersion 
time and drug content as per the IP specifications. the solid 
dispersions prepared by various methods ,The angle of 
repose values obtained for various solid dispersions were in 
the range of 19.56° to 24.28° which indicated the good flow 
properties of dispersions, The Carr's index values obtained 
for various solid dispersions were in the range of 14.17 to 
15.52% which indicated the good flow properties of 
dispersions. The preparation of fast dissolving tablets by 
using newer super disintegrants. 
CONCLUSION 
present search preparation of solid dispersions by physical 
mixing, fusion, solvent evaporation and lyophilization 
methods greatly improved the solubility and dissolution rate 
of poorly soluble drugs, lovastastin and PEG 6000 used as an 
inert amphilic carrier was found suitable for the preparation 
of solid dispersions by various methods. It was observed 
that the order of increased dissolution rate for various solid 
dispersions prepared by different methods were 
lyophilization > solvent evaporation > physical. 
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